Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.70m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Proposed Director Dealing

30 Sep 2020 13:30

RNS Number : 6272A
Science Group PLC
30 September 2020
 

 

 

 

30 September 2020

 

Science Group plc

(the "Company" or "Science Group")

 

 

Proposed Director Dealing

 

Science Group announces that it has been notified by Martyn Ratcliffe, Executive Chairman of the Company of his intention to sell up to 2,000,826 ordinary shares of £0.01 each in the Company ("Sale Shares") at a price of 240 pence per Sale Share (the "Sale").

The Sale Shares represent approximately 4.8% of the Company's issued share capital excluding treasury shares. Assuming all the Sale Shares are sold, Martyn Ratcliffe will, following completion of the Sale, continue to have an interest in approximately 27.25% of the issued share capital (excluding treasury shares) of the Company.

Martyn Ratcliffe has undertaken that he will not dispose of any further ordinary shares for a period of 12 months after completion of the Sale (subject to customary exceptions).

The Company is not a party to the Sale and will not receive any proceeds from the Sale.

Background to the Transaction

In January 2019, at the conclusion of the strategic review, the Board of Science Group highlighted that while "the Company benefits from a supportive shareholder base, the lack of liquidity creates a market inefficiency which may impact the valuation of the Group."

Since 2010, the largest shareholder in the Company has been the Executive Chairman, Martyn Ratcliffe, following his investment in March of that year and the subsequent placing in May 2010. Mr Ratcliffe's current shareholding is 13,412,906 shares equivalent to 32.03% of the issued share capital excluding treasury shares. Due to the scale of Mr Ratcliffe's shareholding, each year shareholders and the Takeover Panel must also approve a waiver of Rule 9 of the Takeover Code in order that the Company can undertake share buy-backs.

Mr Ratcliffe has now agreed to reduce his shareholding in order to broaden the shareholder base and reduce shareholder concentration through the Sale. Following this transaction, Mr Ratcliffe will remain the Group's largest shareholder.

 

End

Science Group plc

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

www.sciencegroup.com

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

Nick Adams, Alex Price

Tel: +44 (0) 20 7710 7600

Liberum Capital Limited (Joint Broker)

Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000

MHP Communications (PR Advisor to Science Group)

Reg Hoare, James Bavister, Pete Lambie

Tel: +44 (0) 20 3128 8100

sciencegroup@mhpc.com

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (No 596/2014). The person responsible for this announcement is Sarah Cole, Company Secretary.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKKBDBBKDCCN
Date   Source Headline
21st Mar 20225:25 pmRNSTransaction in Own Shares
18th Mar 20225:10 pmRNSTransaction in Own Shares
17th Mar 20225:20 pmRNSTransaction in Own Shares
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSAudited Results for year ended 31 December 2021
14th Mar 202211:00 amRNSNotice of Preliminary Results
7th Feb 20227:00 amRNSDirector update
13th Jan 20227:00 amRNS2021 End of Year Trading Update
4th Jan 20223:56 pmRNSTotal Voting Rights
24th Dec 20217:00 amRNSNew Bank Facility
21st Dec 20215:10 pmRNSTransaction in Own Shares
20th Dec 20217:00 amRNSTransaction in Own Shares
16th Dec 202110:30 amRNSCredit Facility to TP Group
26th Nov 20217:00 amRNSFrontier, acquisition and group update
29th Oct 20215:00 pmRNSWithdrawal of GM Requisition - Replacement
29th Oct 20211:20 pmRNSWithdrawal of GM Requisition
26th Oct 20217:00 amRNSRequisition of General Meeting of TP Group plc
15th Oct 20217:00 amRNSIssue of share options & PDMR dealing
11th Oct 20217:00 amRNSTrading and Business Update
30th Sep 20214:45 pmRNSTotal Voting Rights
30th Sep 202111:45 amRNSResult of General Meeting
15th Sep 20217:00 amRNSTR1: Notification of Major Interest in Shares
13th Sep 20214:30 pmRNSTR1: Notification of Major Interest in Shares
13th Sep 20217:00 amRNSNotice of General Meeting
10th Sep 20217:00 amRNSHolding(s) in Company
9th Sep 20217:00 amRNSTP Group General Meeting
8th Sep 20212:00 pmRNSReplacement: Holding(s) in Company
8th Sep 202111:59 amRNSTR1: Notification of Major Interest in Shares
8th Sep 20217:00 amRNSTR1: Notification of Major Interest in Shares
8th Sep 20217:00 amRNSHolding(s) in Company
7th Sep 20211:48 pmRNSConfirmation of fundraising and director dealing
7th Sep 202111:16 amRNSProposed equity placing and director dealing
3rd Sep 202112:00 pmRNSWithdrawal of Possible Offer for TP Group plc
2nd Sep 20215:30 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSForm 8 (DD) - TP Group plc
27th Aug 20215:27 pmRNSForm 8 (DD) - TP Group plc
27th Aug 20217:00 amRNSHolding(s) in Company
27th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
26th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
26th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
26th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
25th Aug 20212:20 pmRNSForm 8 (DD) - TP Group plc
25th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
24th Aug 20215:47 pmRNSHolding(s) in Company
24th Aug 20211:15 pmRNSHolding(s) in Company
24th Aug 20217:01 amRNSStatement re Final Possible Offer for TP Group plc
24th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
23rd Aug 20216:15 pmRNSHolding(s) in Company
23rd Aug 20215:12 pmRNSForm 8.3 - Science Group Plc
23rd Aug 20214:52 pmRNSForm 8.3 - Science Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.